CompletedPhase 2

An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

United States62 participantsStarted 2009-03-25

Plain-language summary

The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of chronic prostatitis * Male adults at least 18 years of age * Moderate to severe chronic prostatitis, with an average pain score above a pre-defined level * To use contraception. Exclusion Criteria: * History of symptoms for less than 3 of the last 6 months * History of recurrent urinary tract infections, or genito-urinary cancer * Use of finasteride or dutasteride within 6 months. * History of hepatitis B, C or human immunodeficiency virus (HIV)

What they're measuring

Change From Baseline in Average Daily Pain Score at Week 6

Timeframe: Baseline, Week 6

Trial details

NCT IDNCT00826514

SponsorPfizer

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-01-11

Results submitted2021-04-20

View on ClinicalTrials.gov More Chronic Prostatitis With Chronic Pelvic Pain Syndrome trials